Molecular Communication: An acid tale of prion formation
- University of Kent, United Kingdom
The transformation of grape juice into an appetising alcoholic beverage is not as straightforward as one might imagine. The yeast Saccharomyces cerevisiae is responsible for fermenting the sugars naturally found in grapes to make ethanol and carbon dioxide. Yet grapes, like many fruits, also contain L-malic acid, which has a sour taste, so the winemaker must trigger a process known as malolactic fermentation to turn the offending L-malic acid into the more palatable and ‘softer’ tasting L-lactic acid.
A variety of bacteria carry out the malolactic fermentation. Such bacteria may already be present on the skin of the grapes or the winemaker can add them after the alcoholic fermentation has taken place. Oenococcus oeni is the bacterium of choice for winemakers, partly because – unlike many other bacteria that produce lactic acid – it does not inhibit the ability of the yeast to ferment sugars.
Louis Pasteur first noted that lactic acid-producing bacteria are often associated with failed wine fermentations over 140 years ago (Pasteur, 1873; Alexandre et al., 2004). Yet, we are only now beginning to understand the complexity of the interplay between these bacteria and yeast during winemaking, thanks largely to the work of the late Susan Lindquist (who died only last month), and Daniel Jarosz, who is now at Stanford University School of Medicine. Now, in eLife, David Garcia of Stanford, David Dietrich and Jon Clardy of Harvard Medical School, and Jarosz report that lactic acid produced by certain bacteria can trigger the formation of the [GAR+] prion in fermenting yeast (Garcia et al., 2016).
Prions are made when proteins undergo a change in conformation and activity that they can sustain themselves and help other proteins to adopt. This in turn gives rise to a heritable form of the protein (known as the amyloid form) that assembles into clumps. However, unlike other yeast prions, the transmission of [GAR+] from cell to cell is not associated with a heritable amyloid. Rather, two other proteins contribute to the formation of the [GAR+] prion in yeast cells (Brown and Lindquist, 2009). But what has the [GAR+] prion got to do with lactic acid and failed wine fermentations?
The [GAR+] prion triggers a remarkable reprogramming of the carbohydrate metabolism in the host cell. By overriding an ancient mechanism that promotes the breakdown of glucose over other sources of carbon, [GAR+] cells are able to metabolise a wide range of other carbon sources, even when glucose is present (Brown and Lindquist, 2009). This is bad news for the winemaker because [GAR+] cells generate less ethanol, which aids the growth of lactic acid-producing bacteria (Figure 1).
Figure 1
Certain bacteria communicate with yeast cells via lactic acid.
L-malic acid (C4H6O5) is a natural component of grapes and other soft fruits, and it is decarboxylated by certain bacteria (red) during malolactic fermentation to produce L-lactic acid (C3H6O3) and carbon dioxide (CO2). The L-lactic acid can then induce the formation of the [GAR+] prion from the [gar-] protein in yeast cells (yellow). Cells carrying this prion (dark yellow) produce less ethanol from the fermentation of sugars, which in turn provides an environment in which the bacteria can flourish. Winemakers try to promote the production of ethanol and reduce levels of malic acid.
Earlier studies by Jarosz and Lindquist found that a wide range of bacteria secrete a chemical messenger (with a low molecular weight) that induces the appearance of [GAR+] in several different yeast species (Jarosz et al., 2014a, 2014b). Since this messenger was resistant to digestion by enzymes, researchers assumed that it was a metabolite. Garcia et al. now report that L-lactic acid can serve as this messenger.
This is not to say that L-lactic acid is the only messenger. Moreover, it is striking that a number of lactic acid-producing bacteria do not induce the [GAR+] prion. These include O. oeni (Jarosz et al., 2014b), whose inability to induce the prion may well contribute to its suitability for wine production. It has been known for over 50 years that the interactions between yeast and the bacteria involved in malolactic fermentation depend on the combinations of species present (Fornachon, 1968), and now we better understand why such variation exists.
The physical structure of the [GAR+] prion and the method by which lactic acid induces its formation remain to be established. However, the new communication mechanism discovered by Garcia et al. is important because it is beneficial to both yeast and bacteria in their native environments, and because it finally explains an observation first made by Pasteur over 140 years ago.
References
-
Saccharomyces cerevisiae-Oenococcus oeni interactions in wine: current knowledge and perspectivesInternational Journal of Food Microbiology 93:141–154.https://doi.org/10.1016/j.ijfoodmicro.2003.10.013
-
A heritable switch in carbon source utilization driven by an unusual yeast prionGenes & Development 23:2320–2332.https://doi.org/10.1101/gad.1839109
-
Influence of different yeasts on the growth of lactic acid bacteria in wineJournal of the Science of Food and Agriculture 19:374–378.https://doi.org/10.1002/jsfa.2740190705
-
BookEtudes Sure Le Vin, Ses Maladies, Causes Qui Les Provoquent Procedes Nouveau Pour Le Conserver Et Pour Le Vieillir (2nd Edition)Paris: Librairie F. Savy.
Article and author information
Author details
Publication history
- Version of Record published: November 29, 2016 (version 1)
Copyright
© 2016, Tuite
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,602
- views
-
- 179
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Molecular Communication: An acid tale of prion formation
eLife 5:e22256.
https://doi.org/10.7554/eLife.22256
Further reading
-
- Cancer Biology
- Chromosomes and Gene Expression
The chromatin-associated protein WD Repeat Domain 5 (WDR5) is a promising target for cancer drug discovery, with most efforts blocking an arginine-binding cavity on the protein called the ‘WIN’ site that tethers WDR5 to chromatin. WIN site inhibitors (WINi) are active against multiple cancer cell types in vitro, the most notable of which are those derived from MLL-rearranged (MLLr) leukemias. Peptidomimetic WINi were originally proposed to inhibit MLLr cells via dysregulation of genes connected to hematopoietic stem cell expansion. Our discovery and interrogation of small-molecule WINi, however, revealed that they act in MLLr cell lines to suppress ribosome protein gene (RPG) transcription, induce nucleolar stress, and activate p53. Because there is no precedent for an anticancer strategy that specifically targets RPG expression, we took an integrated multi-omics approach to further interrogate the mechanism of action of WINi in human MLLr cancer cells. We show that WINi induce depletion of the stock of ribosomes, accompanied by a broad yet modest translational choke and changes in alternative mRNA splicing that inactivate the p53 antagonist MDM4. We also show that WINi are synergistic with agents including venetoclax and BET-bromodomain inhibitors. Together, these studies reinforce the concept that WINi are a novel type of ribosome-directed anticancer therapy and provide a resource to support their clinical implementation in MLLr leukemias and other malignancies.
-
- Chromosomes and Gene Expression
- Immunology and Inflammation
Ikaros is a transcriptional factor required for conventional T cell development, differentiation, and anergy. While the related factors Helios and Eos have defined roles in regulatory T cells (Treg), a role for Ikaros has not been established. To determine the function of Ikaros in the Treg lineage, we generated mice with Treg-specific deletion of the Ikaros gene (Ikzf1). We find that Ikaros cooperates with Foxp3 to establish a major portion of the Treg epigenome and transcriptome. Ikaros-deficient Treg exhibit Th1-like gene expression with abnormal production of IL-2, IFNg, TNFa, and factors involved in Wnt and Notch signaling. While Ikzf1-Treg-cko mice do not develop spontaneous autoimmunity, Ikaros-deficient Treg are unable to control conventional T cell-mediated immune pathology in response to TCR and inflammatory stimuli in models of IBD and organ transplantation. These studies establish Ikaros as a core factor required in Treg for tolerance and the control of inflammatory immune responses.
